Yesterday, the FDA panel asked Dynavax Technologies to present more safety data on its Hepatitis B vaccination. The stock fell 47 percent on the news, and Mad Money host Jim Cramer offers a strategy to play the stock.
Data is a real-time snapshot *Data is delayed at least 15 minutes Market Data Terms of Service
Global Business and Financial News, Stock Quotes, and Market Data and Analysis
More Comments
ADD COMMENTS
PREVIEW COMMENT